NCT05694728 2023-01-23A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV VaccineBeijing Health Guard Biotechnology, IncPhase 2 Completed780 enrolled
NCT05680454 2023-01-17A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV VaccineBeijing Health Guard Biotechnology, IncPhase 1 Completed160 enrolled